Fundraising Fox

Engage Bio

AcquiredYC W22

San Francisco, US · Founded 2021 · 10 employees · 4 known investors

EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.

Founders & leadership· Y Combinator alumni (W22)

Engage Bio was founded in 2021 by Will Olsen.

WOWill Olsen
Will OlseninFounderWill Olsen is co-founder and CEO of Engage Bio.

Investors · 4

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap

Companies competing with Engage Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Engage Bio do?
EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Who founded Engage Bio?
Engage Bio was founded by Will Olsen in 2021.
Who are Engage Bio's investors?
Engage Bio's investors include Metaplanet, SciFounders, WorldQuant Ventures, Y Combinator.
Where is Engage Bio headquartered?
Engage Bio is headquartered in San Francisco, US.